Wednesday, 27 January 2021

GE Healthcare launches second cohort of India Edison Accelerator

17 December 2020 | News

Riding on the success of the first Cohort of the programme, this time the focus is on technology solutions aimed at streamlining healthcare delivery across verticals

Source credit: Shutterstock

Source credit: Shutterstock

‘India Edison Accelerator – Startups powered by GE Healthcare’ announces the launch of its second Cohort, with the enrolment of six remarkable health-tech startups - AarogyaAI, BrainSightAI, Fluid AI, InMed Prognostics, Wellthy Therapeutics and Onward Assist. 

In its second year now, India Edison Accelerator, the company’s first startup collaboration programme based out of India is committed to mentoring and creating strategic partners to co-develop healthcare solutions alongside GE’s engineers and scientists.

Riding on the success of the first Cohort of the programme, this time the focus is on technology solutions aimed at streamlining healthcare delivery across verticals- Advanced Imaging and Visualisation, Precision Diagnosis and Treatment, Computer-aided Detection and Diagnosis, Point-of-Care Diagnostics, Remote Patient Monitoring,  Virtual Hospitals, Data Management and Insights, and Asset Health Monitoring.

Girish Raghavan, VP, Software Engineering, GE Healthcare South Asia said, “The aim of this programme is to harness the brainpower of the start-up ecosystem for developing solutions on the Edison platform for some of the toughest healthcare challenges existing today.”

‘India Edison Accelerator – Startups powered by GE Healthcare’ is providing a zero-equity cash-in-grant of $10000 to each of the selected startups. In addition, they will have access to mentorship, skill development programmes, commercial and regulatory guidance, and data provision as additional benefits.

About the six startups:

  • AarogyaAI: enables quick and accurate diagnosis of DR-TB so that the patient can be rightly prescribed effective drug combinations for treatment, instantly.
  • BrainSightAI: is building an MRI-bases SAAS platform, which can transform how neuropsychiatric disorders are addressed.
  • Fluid AI: offers data driven solutions backed with AI analytics and insights that can help businesses take smarter decisions with respect to operations, sales, credit etc.
  • InMed Prognostics: is an artificial intelligence and machine learning based MRI tool, helping neuro-radiologists, neuro physicians and psychiatrists understand the brain better and effects of different conditions.
  • Wellthy Therapeutics maps the patient journey and plays a 24*7, continual real-time role to patients as a companion solution to help them manage their chronic conditions better.
  • Onward Assist: is an advanced cancer prognostics platform for histopathologists and radiologists, building machine learning models to support decision making and improve outcomes.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls